CTMX — CYTOMX THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in CYTOMX THERAPEUTICS INC (CTMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.0%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 249,900 +174,900 +233.2% 0.01% $797K $3.19
2025 Q2 INITIATED 75,000 — — 0.00% $170K $2.27
% of Fund (quarterly)    CTMX price (monthly, adj. close)

Other funds also holding CTMX

As of 2025 Q4 — sorted by position size

VR Adviser, LLC 3Y 3.27% Kynam Capital Management, LP 3Y 2.44% Commodore Capital LP 3Y 2.18% Exome Asset Management LLC 1.52% ADAR1 Capital Management, LLC 1.29% Ikarian Capital, LLC 3Y 1.06% Elmind Capital, LP 0.88% Vivo Capital, LLC 3Y 7Y 0.79% STEMPOINT CAPITAL LP 0.76% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.74%
← Back to Caption Management, LLC Holdings